Stakeholders want Makary’s voucher program paused, call for FDA independence
“The need for a fiercely independent, reliable and credible FDA is more critical now more than ever.” - @janetkrommes.bsky.social
www.biospace.com/fda/stakehol...
The FDA hasn’t been transparent and open enough with how it has implemented the Commissioner’s National Priority Voucher program, patient, industry and trade groups said Thursday.
